Retatrutide / Ozempic 2.0
Retatrutide is an experimental weight-loss and diabetes drug developed by Eli Lilly. It's a triple-hormone receptor agonist, meaning it activates three hormone receptors involved in regulating appetite, metabolism, and blood sugar: How It Works:
GLP-1 & GIP help reduce appetite, slow stomach emptying, and increase insulin secretion.
Glucagon receptor activation may help increase energy expenditure (burning more calories).
This triple action aims to enhance weight loss and improve metabolic control more than drugs that target only one or two of these hormones (like semaglutide/Ozempic or tirzepatide/ Mounjaro). ozempic 2
Retatrutide
3 ml bacteria static water to powder
Keep refrigerated
Lowest dose 15iu sub q every 7 days
Medium dose 30iu sub q every 7 days
Max dose 60iu sub q every 7 days
















